Blocking CXCR4 can promote autophagy in macrophages, alleviate atherosclerosis, improve myocardial structure, reduce the severity of coronary artery disease, and reverse atherosclerosis induced by Chlamydia pneumoniae infection by blocking TLR2/CXCR4 [7]. Here, CXCR4 is linked to coronary artery disorder.